Phase I trial segment has been expected to grow at the fastest growth rate during the forecast period, owing to the increase in its applications in investigative new drug
(IND) sector, technological advancements, and the rising government initiatives to improve the healthcare sector in emerging economies.
M2 PHARMA-November 15, 2018-Generon Receives Investigative New Drug
Approval from China SFDA for A-319 to Treat Patients with B Cell Malignancies
Stemedica's MSCs are also being used in five other FDA-approved clinical trials under Investigative New Drug
The decision to seek an Orphan Drug Designation submission is part of PixarBio's plan to prepare an Investigative New Drug
Application (NDA) for spinal cord injury.
This US FDA orphan drug designation allows the company to move forward with its preparation of an Investigative New Drug
Application and proposal of clinical trials.
DS: A practical goal of the work supported by this grant is to generate data in support of an IND (Investigative New Drug
) proposal to the FDA.
During this fiscal year, the company also plans to file an Investigative New Drug
(IND) for a pivotal Phase 3 clinical trial of Revimmune, to treat numerous autoimmune diseases with an initial indication targeting refractory relapsing-remitting Multiple Sclerosis.
The company plans to submit an IND (Investigative New Drug
Application) this year.
[para] filing of an Investigative New Drug
Application (INDA) with the Food and Drug Administration, along with all required documentation;
Preclinical data submitted as part of the company's Investigative New Drug
application demonstrated that HuCNS-SC cells protect host photoreceptors and preserve vision in a well-established animal model of retinal disease that is relevant to dry AMD.
Stem cell company Stemedica Cell Technologies Inc reported on Friday that the company has filed an Investigative New Drug
(IND) application with the US Food and Drug Administration (FDA) for treatment of stroke with adult allogeneic mesenchymal stem cells.
MedImmune currently anticipates filing an Investigative New Drug
(IND) application with the United States Food and Drug Administration for the lead anti-IL-9 antibody in the second half of 2003.